Toward Personalized Sexual Medicine (Part 1): Integrating the "Dual Control Model" into Differential Drug Treatments for Hypoactive Sexual Desire Disorder and Female Sexual Arousal Disorder

Journal of Sexual Medicine

Volumn 10, Issue 3, 2013, Pages 791-809

  Bloemers, Jos ^a,b   van Rooij, Kim ^a,b   Poels, Saskia ^a,b   Goldstein, Irwin ^c   Everaerd, Walter ^d   Koppeschaar, Hans ^a   Chivers, Meredith ^e   Gerritsen, Jeroen ^a,b,f   van Ham, Diana ^a,b   Olivier, Berend ^b,g   Tuiten, Adriaan ^a,b  

^a Emotional Brain BV   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c San Diego Sexual Medicine   (United States)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e QUEEN S UNIVERSITY   (Canada)

^f ALAN TURING INSTITUTE   (United Kingdom)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cue Sensitivity; Hypoactive Sexual Desire Disorder; Serotonin; Sexual Excitation; Sexual Inhibition; Testosterone

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SEROTONIN; SEROTONIN 1A AGONIST; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE;

ARTICLE; FEMALE SEXUAL AROUSAL DISORDER; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; NONHUMAN; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUALITY; SOCIAL BEHAVIOR; TESTOSTERONE BLOOD LEVEL;

EID: 84874752025     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02984.x     Document Type: Article

References (109)

1. Fugl-Meyer K, Fugl-Meyer AR. Sexual disabilities are not singularities. Int J Impot Res 2002;14:487-93.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the united states: Prevalence and predictors. JAMA 1999;281:537-44.
3. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in united states women: Prevalence and correlates. Obstet Gynecol 2008;112:970-8.
4. Davison SL, Bell RJ, LaChina M, Holden SL, Davis SR. The relationship between self-reported sexual satisfaction and general well-being in women. J Sex Med 2009;6:2690-7.
5. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Text Revision. Washington, DC: American Psychiatric Association; 2000.
6. Tuiten A, Van Honk J, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000;57:149-53; discussion 155-6.
7. Tuiten A, van Honk J, Verbaten R, Laan E, Everaerd W, Stam H. Can sublingual testosterone increase subjective and physiological measures of laboratory-induced sexual arousal? Arch Gen Psychiatry 2002;59:465-6.
8. Eisenegger C, Naef M, Snozzi R, Heinrichs M, Fehr E. Prejudice and truth about the effect of testosterone on human bargaining behaviour. Nature 2010;463:356-9.
9. van der Made F, Bloemers J, van Ham D, El Yassem W, Kleiverda G, Everaerd W, Olivier B, Tuiten A. Childhood sexual abuse, selective attention for sexual cues and the effects of testosterone with or without vardenafil on physiological sexual arousal in women with sexual dysfunction: A pilot study. J Sex Med 2009;6:429-39.
10. van der Made F, Bloemers J, Yassem WE, Kleiverda G, Everaerd W, van Ham D, Olivier B, Koppeschaar H, Tuiten A. The influence of testosterone combined with a PDE5-inhibitor on cognitive, affective, and physiological sexual functioning in women suffering from sexual dysfunction. J Sex Med 2009;6:777-90.
11. Pfaff D, Schwartz-Giblin S, McCarthy M, Kow L. Cellular and molecular mechanisms of female reproductive behaviors. New York: Raven Press; 1994.
12. McCarthy MM, Albrecht ED. Steroid regulation of sexual behavior. Trends Endocrinol Metab 1996;7:324-7.
13. Freeman LM, Rissman EF. Neural aromatization and the control of sexual behavior. Trends Endocrinol Metab 1996;7:334-8.
14. Waxenberg SE, Drellich MG, Sutherland AM. The role of hormones in human behavior. I. Changes in female sexuality after adrenalectomy. J Clin Endocrinol Metab 1959;19:193-202.
15. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985;47:339-51.
16. Dabbs J, Dabbs M. Heroes, rogues, and lovers: Testosterone and behavior. New York: McGraw-Hill; 2000.
17. Liening SH, Josephs RA. It is not just about testosterone: Physiological mediators and moderators of testosterone?s behavioral effects. Soc Personal Psychol Compass 2010;4:982-94.
18. Mazur A, Booth A. Testosterone and dominance in men. Behav Brain Sci 1998;21:353-63; discussion 363-97.
19. Geary D. Competing for mates. In: Geary DC, ed. Male, Female: The Evolution of Human Sex Differences. 2nd Ed. Washington, DC: American Psychological Association; 2010:213-45.
20. Schmitt DP, Buss DM. Strategic self-promotion and competitor derogation: Sex and context effects on the perceived effectiveness of mate attraction tactics. J Pers Soc Psychol 1996;70:1185-204.
21. Slatcher RB, Mehta PH, Josephs RA. Testosterone and self-reported dominance interact to influence human mating behavior. Soc Psychol Personal Sci 2011;2:531-9.
22. Wingfield JC, Hegner RE, Dufty AM Jr, Ball GF. The "challenge hypothesis": Theoretical implications for patterns of testosterone secretion, mating systems, and breeding strategies. Am Nat 1990;136:829-46.
23. Beehner JC, Phillips-Conroy JE, Whitten PL. Female testosterone, dominance rank, and aggression in an ethiopian population of hybrid baboons. Am J Primatol 2005;67:101-19.
24. Hermans EJ, Bos PA, Ossewaarde L, Ramsey NF, Fernandez G, van Honk J. Effects of exogenous testosterone on the ventral striatal BOLD response during reward anticipation in healthy women. Neuroimage 2010;52:277-83.
25. Rose RM, Berstein IS, Gordon TP. Consequences of social conflict on plasma testosterone levels in rhesus monkeys. Psychosom Med 1975;37:50-61.
26. Rose RM, Gordon TP, Bernstein IS. Plasma testosterone levels in the male rhesus: Influences of sexual and social stimuli. Science 1972;178:643-5.
27. Kreuz LE, Rose RM. Assessment of aggressive behavior and plasma testosterone in a young criminal population. Psychosom Med 1972;34:321-32.
28. Thompson WM, Dabbs JM, Frady RL. Changes in saliva testosterone levels during a 90-day shock incarceration program. Crim Justice Behav 1990;17:246-52.
29. Roney JR, Mahler SV, Maestripieri D. Behavioral and hormonal responses of men to brief interactions with women. Evol Hum Behav 2003;24:365-75.
30. Hellhammer DH, Hubert W, Schürmeyer T. Changes in saliva testosterone after psychological stimulation in men. Psychoneuroendocrinology 1985;10:77-81.
31. van Anders SM, Hamilton LD, Schmidt N, Watson NV. Associations between testosterone secretion and sexual activity in women. Horm Behav 2007;51:477-82.
32. Hamilton LD, Meston CM. The effects of partner togetherness on salivary testosterone in women in long distance relationships. Horm Behav 2010;57:198-202.
33. Goldey KL, van Anders SM. Sexual thoughts: Links to testosterone and cortisol in men. Arch Sex Behav 2011. doi: 10.1007/s10508-011-9858-6.
34. Granger DA, Shirtcliff EA, Booth A, Kivlighan KT, Schwartz EB. The "trouble" with salivary testosterone. Psychoneuroendocrinology 2004;29:1229-40.
35. Liening SH, Stanton SJ, Saini EK, Schultheiss OC. Salivary testosterone, cortisol, and progesterone: Two-week stability, interhormone correlations, and effects of time of day, menstrual cycle, and oral contraceptive use on steroid hormone levels. Physiol Behav 2010;99:8-16.
36. Cottingham SL, Pfaff D. Interconnectedness of steroid-binding hormones: Existence and implications. In: Ganten D, Pfaff DW, eds. Current topics in neuroendocrinology. Vol. 7. Berlin: Springer; 1986:223-40.
37. Sherwin BB, Gelfand MM. The role of androgen in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 1987;49:397-409.
38. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum A, Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005;90:5226-33.
39. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA, Jones KP, Daugherty CA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000;343:682-8.
40. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005;165:1582-9.
41. Buster JE, Kingsberg SA, Aguirre O, Brown C, Breaux JG, Buch A, Rodenberg CA, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005;105:944-52.
42. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003;79:1341-52.
43. Davis SR, McCloud P, Strauss BJ, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995;21:227-36.
44. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J, APHRODITE Study Team. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008;359:2005-17.
45. Nathorst-Boos J, Floter A, Jarkander-Rolff M, Carlstrom K, Schoultz B. Treatment with percutanous testosterone gel in postmenopausal women with decreased libido-Effects on sexuality and psychological general well-being. Maturitas 2006;53:11-8.
46. El-Hage G, Eden JA, Manga RZ. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder. Climacteric 2007;10:335-43.
47. Davis S, Papalia MA, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BG, Wlodarczyk J, Gard'ner K, Humberstone A. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: A randomized trial. Ann Intern Med 2008;148:569-77.
48. Braunstein GD. Safety of testosterone treatment in postmenopausal women. Fertil Steril 2007;88:1-17.
49. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Yang HM, Nolan J. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 1999;44:1012-20.
50. Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med 2006;166:1483-9.
51. Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH, Endocrine Society. Postmenopausal hormone therapy: An endocrine society scientific statement. J Clin Endocrinol Metab 2010;95:s1-66.
52. Slagter MH, Gooren LJ, Scorilas A, Petraki CD, Diamandis EP. Effects of long-term androgen administration on breast tissue of female-to-male transsexuals. J Histochem Cytochem 2006;54:905-10.
53. Davis SR, Braunstein GD. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2012;9:1134-48.
54. Tuiten A, Laan E, Panhuysen G, Everaerd W, de Haan E, Koppeschaar H, Vroon P. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom Med 1996;58:234-41.
55. Aleman A, Bronk E, Kessels RP, Koppeschaar HP, van Honk J. A single administration of testosterone improves visuospatial ability in young women. Psychoneuroendocrinology 2004;29:612-7.
56. Bos PA, Terburg D, van Honk J. Testosterone decreases trust in socially naive humans. Proc Natl Acad Sci U S A 2010;107:9991-5.
57. Hermans EJ, Putman P, van Honk J. Testosterone administration reduces empathetic behavior: A facial mimicry study. Psychoneuroendocrinology 2006;31:859-66.
58. Hermans EJ, Putman P, Baas JM, Gecks NM, Kenemans JL, van Honk J. Exogenous testosterone attenuates the integrated central stress response in healthy young women. Psychoneuroendocrinology 2007;32:1052-61.
59. Hermans EJ, Ramsey NF, van Honk J. Exogenous testosterone enhances responsiveness to social threat in the neural circuitry of social aggression in humans. Biol Psychiatry 2008;63:263-70.
60. Schutter DJ, van Honk J. Decoupling of midfrontal delta-beta oscillations after testosterone administration. Int J Psychophysiol 2004;53:71-3.
61. van Honk J, Schutter DJ, Hermans EJ, Putman P, Tuiten A, Koppeschaar H. Testosterone shifts the balance between sensitivity for punishment and reward in healthy young women. Psychoneuroendocrinology 2004;29:937-43.
62. van Honk J, Peper JS, Schutter DJ. Testosterone reduces unconscious fear but not consciously experienced anxiety: Implications for the disorders of fear and anxiety. Biol Psychiatry 2005;58:218-25.
63. van Honk J, Schutter DJ. Testosterone reduces conscious detection of signals serving social correction: Implications for antisocial behavior. Psychol Sci 2007;18:663-7.
64. Postma A, Meyer G, Tuiten A, van Honk J, Kessels RP, Thijssen J. Effects of testosterone administration on selective aspects of object-location memory in healthy young women. Psychoneuroendocrinology 2000;25:563-75.
65. Bos PA, Panksepp J, Bluthe RM, Honk JV. Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: A review of single administration studies. Front Neuroendocrinol 2011;33:17-35.
66. Gooren LJ. Human male sexual functions do not require aromatization of testosterone: A study using tamoxifen, testolactone, and dihydrotestosterone. Arch Sex Behav 1985;14:539-48.
67. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER. Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 1997;337:91-5.
68. Carani C, Granata AR, Rochira V, Caffagni G, Aranda C, Antunez P, Maffei LE. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism. Psychoneuroendocrinology 2005;30:413-7.
69. Roselli CE, Horton LE, Resko JA. Time-course and steroid specificity of aromatase induction in rat hypothalamus-preoptic area. Biol Reprod 1987;37:628-33.
70. Balthazart J, Foidart A, Hendrick JC. The induction by testosterone of aromatase activity in the preoptic area and activation of copulatory behavior. Physiol Behav 1990;47:83-94.
71. Davis SR, Goldstat R, Papalia MA, Shah S, Kulkarni J, Donath S, Bell RJ. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: A randomized, placebo-controlled trial. Menopause 2006;13:37-45.
72. Stuenkel CA, Dudley RE, Yen SS. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men. J Clin Endocrinol Metab 1991;72:1054-9.
73. Salehian B, Wang C, Alexander G, Davidson T, McDonald V, Berman N, Dudley RE, Ziel F, Swerdloff RS. Pharmacokinetics, bioefficacy, and safety of sublingual testosterone cyclodextrin in hypogonadal men: Comparison to testosterone enanthate-A clinical research center study. J Clin Endocrinol Metab 1995;80:3567-75.
74. van Rooij K, Bloemers J, de Leede L, Goldstein I, Lentjes E, Koppeschaar H, Olivier B, Tuiten A. Pharmacokinetics of three doses of sublingual testosterone in healthy premenopausal women. Psychoneuroendocrinology 2012;37:773-81.
75. Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007;4:1001-8.
76. Bancroft J. Human sexuality and its problems. London: Churchill Livingstone; 1989.
77. Bancroft J, Graham CA, Janssen E, Sanders SA. The dual control model: Current status and future directions. J Sex Res 2009;46:121-42.
78. Laan E, Everaerd W, Evers A. Assessment of female sexual arousal: Response specificity and construct validity. Psychophysiology 1995;32:476-85.
79. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS. Androgen receptor defects: Historical, clinical, and molecular perspectives. Endocr Rev 1995;16:271-321.
80. Berenbaum SA, Bryk KK, Nowak N, Quigley CA, Moffat S. Fingers as a marker of prenatal androgen exposure. Endocrinology 2009;150:5119-24.
81. Childress AR, Ehrman RN, Wang Z, Li Y, Sciortino N, Hakun J, etal. Prelude to passion: Limbic activation by "unseen" drug and sexual cues. PloS ONE 2008;3:e1506.
82. Prause N, Janssen E, Hetrick WP. Attention and emotional responses to sexual stimuli and their relationship to sexual desire. Arch Sex Behav 2008;37:934-49.
83. Williams JM, Mathews A, MacLeod C. The emotional Stroop task and psychopathology. Psychol Bull 1996;120:3-24.
84. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-404.
85. Janssen E, Bancroft J. The dual control model: The role of sexual inhibition and excitation in sexual arousal and behaviour. In: Janssen E, ed. The psychophysiology of sex. Bloomington: Indiana University Press; 2007:197.
86. Chambers CD, Garavan H, Bellgrove MA. Insights into the neural basis of response inhibition from cognitive and clinical neuroscience. Neurosci Biobehav Rev 2009;33:631-46.
87. Beauregard M, Levesque J, Bourgouin P. Neural correlates of conscious self-regulation of emotion. J Neurosci 2001;21:RC165.
88. Stoleru S, Redoute J, Costes N, Lavenne F, Bars DL, Dechaud H, Forest MG, Pugeat M, Cinotti L, Pujol JF. Brain processing of visual sexual stimuli in men with hypoactive sexual desire disorder. Psychiatry Res 2003;124:67-86.
89. Karama S, Lecours AR, Leroux JM, Bourgouin P, Beaudoin G, Joubert S, Beauregard M. Areas of brain activation in males and females during viewing of erotic film excerpts. Hum Brain Mapp 2002;16:1-13.
90. Stoleru S, Gregoire MC, Gerard D, Decety J, Lafarge E, Cinotti L, Lavenne F, Le Bars D, Vernet-Maury E, Rada H, Collet C, Mazoyer B, Forest MG, Magnin F, Spira A, Comar D. Neuroanatomical correlates of visually evoked sexual arousal in human males. Arch Sex Behav 1999;28:1-21.
91. Rubia K, Russell T, Overmeyer S, Brammer MJ, Bullmore ET, Sharma T, Simmons A, Williams SC, Giampietro V, Andrew CM, Taylor E. Mapping motor inhibition: Conjunctive brain activations across different versions of go/no-go and stop tasks. Neuroimage 2001;13:250-61.
92. Liddle PF, Kiehl KA, Smith AM. Event-related fMRI study of response inhibition. Hum Brain Mapp 2001;12:100-9.
93. Liu X, Banich MT, Jacobson BL, Tanabe JL. Common and distinct neural substrates of attentional control in an integrated simon and spatial Stroop task as assessed by event-related fMRI. Neuroimage 2004;22:1097-106.
94. Milham MP, Banich MT, Barad V. Competition for priority in processing increases prefrontal cortex's involvement in top-down control: An event-related fMRI study of the Stroop task. Brain Res Cogn Brain Res 2003;17:212-22.
95. Konishi S, Jimura K, Asari T, Miyashita Y. Transient activation of superior prefrontal cortex during inhibition of cognitive set. J Neurosci 2003;23:7776-82.
96. Joseph R. Environmental influences on neural plasticity, the limbic system, emotional development and attachment: A review. Child Psychiatry Hum Dev 1999;29:189-208.
97. Janssen E, Everaerd W, Van Lunsen RH, Oerlemans S. Validation of a psychophysiological waking erectile assessment (WEA) for the diagnosis of male erectile disorder. Urology 1994;43:686-95; discussion 695-6.
98. Bloemers J, Van der Made F, Everaerd W, Olivier B, Tuiten A. The neural correlates of female sexual dysfunction. ISSWSH. 2007.
99. Bancroft J. Central inhibition of sexual response in the male: A theoretical perspective. Neurosci Biobehav Rev 1999;23:763-84.
100. Eagle DM, Bari A, Robbins TW. The neuropsychopharmacology of action inhibition: Cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berl) 2008;199:439-56.
101. Evers EA, Cools R, Clark L, van der Veen FM, Jolles J, Sahakian BJ, Robbins TW. Serotonergic modulation of prefrontal cortex during negative feedback in probabilistic reversal learning. Neuropsychopharmacology 2005;30:1138-47.
102. Sprouse JS, Aghajanian GK. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1987;1:3-9.
103. Hamon M, Fattaccini CM, Adrien J, Gallissot MC, Martin P, Gozlan H. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties. J Pharmacol Exp Ther 1988;246:745-52.
104. Liu YP, Wilkinson LS, Robbins TW. Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. Psychopharmacology (Berl) 2004;173:175-85.
105. Lutfey KE, Link CL, Litman HJ, Rosen RC, McKinlay JB. An examination of the association of abuse (physical, sexual, or emotional) and female sexual dysfunction: Results from the Boston area community health survey. Fertil Steril 2008;90:957-64.
106. Labrie F, Belanger A, Simard J, Van L, Labrie C. DHEA and peripheral androgen and estrogen formation: Intracinology. Ann N Y Acad Sci 1995;774:16-28.
107. Beevers CG, Ellis AJ, Wells TT, McGeary JE. Serotonin transporter gene promoter region polymorphism and selective processing of emotional images. Biol Psychol 2010;83:260-5.
108. Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD, Sequeira A, Kushwaha N, Morris SJ, Basak A, Ou XM, Albert PR. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23:8788-99.
109. Bloemers J, Gerritsen J, Bults R, Koppeschaar H, Everaerd W, Olivier B, Tuiten A. Induction of sexual arousal in women under conditions of institutional and ambulatory laboratory circumstances: A comparative study. J Sex Med 2010;7:1160-76.